Nuwellis (NUWE) Cash from Operations Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.38% |
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 6.50% |
| Jun 30, 2025 | 8.47% |
| Mar 31, 2025 | 14.33% |
| Dec 31, 2024 | 17.89% |
| Sep 30, 2024 | 6.53% |
| Jun 30, 2024 | 7.04% |
| Mar 31, 2024 | 10.22% |
| Dec 31, 2023 | -0.27% |
| Sep 30, 2023 | -2.60% |
| Jun 30, 2023 | -8.82% |
| Mar 31, 2023 | -3.93% |
| Dec 31, 2022 | 0.15% |
| Sep 30, 2022 | -1.18% |
| Jun 30, 2022 | 0.73% |
| Mar 31, 2022 | -24.50% |
| Dec 31, 2021 | -8.77% |
| Sep 30, 2021 | -0.27% |
| Jun 30, 2021 | -2.12% |
| Mar 31, 2021 | 1.13% |
| Dec 31, 2020 | 6.45% |
| Sep 30, 2020 | 4.08% |
| Jun 30, 2020 | 10.62% |
| Mar 31, 2020 | 4.95% |
| Dec 31, 2019 | 5.28% |
| Sep 30, 2019 | 8.62% |
| Jun 30, 2019 | 5.40% |
| Mar 31, 2019 | 6.00% |
| Dec 31, 2018 | 13.49% |
| Sep 30, 2018 | 4.26% |
| Jun 30, 2018 | 0.09% |
| Mar 31, 2018 | -4.13% |
| Dec 31, 2017 | 1.61% |
| Sep 30, 2017 | -1.50% |
| Jun 30, 2017 | -14.81% |
| Mar 31, 2017 | 19.48% |
| Dec 31, 2016 | 4.46% |
| Sep 30, 2016 | -5.13% |
| Jun 30, 2016 | -0.18% |
| Mar 31, 2016 | -15.24% |